|
GDAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
9.52410372789814E-11 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.700000E-03 |
| Stage1-vs-Stage3 |
1.211040E-01 |
| Stage1-vs-Stage4 |
1.615490E-04 |
| Stage2-vs-Stage3 |
9.59809999999672E-05 |
| Stage2-vs-Stage4 |
5.18699999951799E-07 |
| Stage3-vs-Stage4 |
3.999500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
8.3011375551223E-13 |
| Normal-vs-Asian |
1.62625468647093E-12 |
| Caucasian-vs-AfricanAmerican |
8.996200E-01 |
| Caucasian-vs-Asian |
3.027200E-01 |
| AfricanAmerican-vs-Asian |
5.584800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
1.406760E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.04499999997731E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.058600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.139600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.246600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.272600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.033000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.549000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.77081999999107E-05 |
| Classical-VS-Follicular |
2.214200E-01 |
| Classical-VS-Other |
2.465600E-01 |
| Classical-VS-Normal |
1.62525548574877E-12 |
| Tall-VS-Follicular |
1.7000099999942E-05 |
| Tall-VS-Other |
5.788400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.632350E-01 |
| Follicular-VS-Normal |
1.67910130244309E-12 |
| Other-VS-Normal |
4.16250000001561E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
4.012400E-02 |
|
|
